Medical device companies' aggregate spend on payment and other gifts to physicians was at least $200 million last year, according to the U.S. Health & Human Services Dept., but critics (and the agency itself) flag widespread problems with the Open Payments database.
The FDA adds a 'black box' warning to the labels on laparoscopic power morcellators, advising against their use in most women slated for fibroid surgery.
The FDA today put so-called "black box" warnings on the labels for laparoscopic power morcellators advising doctors that the devices, until recently a mainstay of gynecological surgery, be avoided in nearly all fibroid-removal procedures.
Here's a look at some of the top legal news stories for medical device companies this week: J&J demands $7.2 billion from Boston Scientific as trial begins; Bard still on the hook for its share of $5m pelvic mesh verdict; Boston Scientific to pay $18.5m in pelvic mesh case; Justice Dept. recoups $6B in False Claims Act cases